Intracoronary transfusion of circulation-derived CD34+ cells improves left ventricular function in patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention

Critical Care Medicine

Volumn 43, Issue 10, 2015, Pages 2117-2132

  Lee, Fan Yen ^a   Chen, Yung Lung ^a   Sung, Pei Hsun ^a   Ma, Ming Chun ^a   Pei, Sung Nan ^a   Wu, Chiung Jen ^a   Yang, Cheng Hsu ^a   Fu, Morgan ^a   Ko, Sheung Fat ^a   Leu, Steve ^a   Yip, Hon Kan ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; CD34+ cells; Clinical outcome; Diffuse coronary artery disease; Heart function

Indexed keywords

ANGIOPOIETIN 1; CD34 ANTIGEN; EPIDERMAL GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; AUTOLOGOUS CD34+ CELL INFUSION; CARDIOVASCULAR MAGNETIC RESONANCE; CELL COUNT; CELL THERAPY; CIRCULATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY SINUS; DOUBLE BLIND PROCEDURE; ENDOTHELIAL PROGENITOR CELL; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HUMAN CELL; INTRACORONARY TRANSFUSION; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STEM CELL CULTURE; SURVIVAL RATE; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; COMPLICATION; CORONARY BLOOD VESSEL; ETIOLOGY; LYMPHOCYTE TRANSFUSION; MIDDLE AGED; PHASE 1 CLINICAL TRIAL; PROCEDURES; TRANSPLANTATION;

AGED; CD4-POSITIVE T-LYMPHOCYTES; CORONARY ARTERY DISEASE; CORONARY VESSELS; DOUBLE-BLIND METHOD; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84941884942     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001138     Document Type: Article

References (18)

1. Held C, Asenblad N, Bassand JP, et al: Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: Results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2011;57:672-684
2. Ho YC, Tsai TH, Sung PH, et al: Minimizing door-to-balloon time is not the most critical factor in improving clinical outcome of ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Crit Care Med 2014;42:1788-1796
3. Lin YS, Fang HY, Hussein H, et al: Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention. EuroIntervention 2014;9:1173-1180
4. Gegouskov V, Tochtermann U, Badowski-Zyla D, et al: Long-term results after coronary artery reconstructive surgery. Thorac Cardiovasc Surg 2007;55:293-297
5. Jolicoeur EM, Cartier R, Henry TD, et al: Patients with coronary artery disease unsuitable for revascularization: Definition, general principles, and a classification. Can J Cardiol 2012;28:S50-S59
6. Henry TD, Satran D, Jolicoeur EM: Treatment of refractory angina in patients not suitable for revascularization. Nat Rev Cardiol 2014;11:78-95
7. Dill T, Schächinger V, Rolf A, et al: Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: Results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am Heart J 2009;157:541-547
8. Fisher SA, Dorée C, Brunskill SJ, et al: Bone marrow stem cell treatment for ischemic heart disease in patients with no option of revascularization: A systematic review and meta-analysis. PLoS One 2013;8:e64669
9. Leu S, Sun CK, Sheu JJ, et al: Autologous bone marrow cell implantation attenuates left ventricular remodeling and improves heart function in porcine myocardial infarction: An echocardiographic, sixmonth angiographic, and molecular-cellular study. Int J Cardiol 2011;150:156-168
10. Tendera M, Wojakowski W, Ruzyllo W, et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: Results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 2009;30:1313-1321.
11. Wollert KC, Meyer GP, Lotz J, et al: Intracoronary autologous bonemarrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004;364:141-148
12. Wang S, Cui J, Peng W, et al: Intracoronary autologous CD34+ stem cell therapy for intractable angina. Cardiology 2010;117:140-147
13. Losordo DW, Henry TD, Davidson C, et al; ACT34-CMI Investigators: Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res 2011;109:428-436
14. Yip HK, Chang LT, Chang WN, et al: Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 2008;39:69-74
15. Kapetanakis S, Kearney MT, Siva A, et al: Real-time three-dimensional echocardiography: A novel technique to quantify global left ventricular mechanical dyssynchrony. Circulation 2005;112:992-1000
16. Jimenez-Quevedo P, Gonzalez-Ferrer JJ, Sabate M, et al: Selected CD133. progenitor cells to promote angiogenesis in patients with refractory angina: Final results of the PROGENITOR randomized trial. Circ Res 2014;115:950-960
17. Wang CH, Verma S, Hsieh IC, et al: Enalapril increases ischemiainduced endothelial progenitor cell mobilization through manipulation of the CD26 system. J Mol Cell Cardiol 2006;41:34-43
18. Yip HK, Sun CK, Tsai TH, et al: Tissue plasminogen activator enhances mobilization of endothelial progenitor cells and angiogenesis in murine limb ischemia. Int J Cardiol 2013;168:226-236